Amersham Biosciences, the life sciences business of Amersham plc (LSE: NYSE: OSE: AHM) has announced an agreement with BioDiscovery Inc. (Marina del Rey, CA) to co-develop and commercialize software for the automated analysis of Amersham Biosciences' CodeLink™ Bioarrays.

Accelrys Announces Updated Modeling And Simulation Software Environment With Novel Scientific Functionalities

Leading laboratory software developer, Autoscribe, is pleased to announce the success of its recent annual LIMS user group meeting.